BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9375452)

  • 21. Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
    Sy J; Vitarelli A; Gheorghiade M
    Minerva Cardioangiol; 1993 Nov; 41(11):535-41. PubMed ID: 8127455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of calcium channel blocking agents in angina pectoris.
    Breland BD; Boland MJ
    J Miss State Med Assoc; 1984 Mar; 25(3):57-62. PubMed ID: 6371246
    [No Abstract]   [Full Text] [Related]  

  • 25. Rational use of calcium-channel antagonists in Raynaud's phenomenon.
    Sturgill MG; Seibold JR
    Curr Opin Rheumatol; 1998 Nov; 10(6):584-8. PubMed ID: 9812220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium antagonists and chronic cardiac failure.
    Kendall MJ; Horton RC; Smith SR
    Postgrad Med J; 1986 Aug; 62(730):713-7. PubMed ID: 3534840
    [No Abstract]   [Full Text] [Related]  

  • 27. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction].
    Yoshida K; Fujii Y; Ina H; Fujioka S; Maseki T; Abe T
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):86-92. PubMed ID: 2329309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
    Hansen JF
    J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of supraventricular tachyarrhythmias with intravenous calcium channel blockers: are subtle differences worth the cost?
    Cheiman DM; Shea BF; Kelly RA
    Pharmacotherapy; 1996; 16(5):861-8. PubMed ID: 8888080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium antagonists. Properties and current indications].
    Amoroso A; Lanciotti G; Mammarella A
    Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795
    [No Abstract]   [Full Text] [Related]  

  • 33. Amlodipine story not finished yet.
    Kisch GL
    Am J Hosp Pharm; 1994 Jun; 51(12):1579. PubMed ID: 8092163
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
    Fugit MD; Rubal BJ; Donovan DJ
    J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
    Seu V; Abrile PG; Boero E; Magaia O; Mocini A; Castrignano A; Maffei P; Perugini P; Livi A
    Minerva Cardioangiol; 1984 Oct; 32(10):639-46. PubMed ID: 6396533
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical use of calcium channel blockers.
    Mayer WP
    Alaska Med; 1984; 26(1):10-2. PubMed ID: 6539573
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium channel blockers in heart failure.
    Elkayam U; Shotan A; Mehra A; Ostrzega E
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):139A-144A. PubMed ID: 8376684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockade in heart failure.
    Guazzi MD; Bartorelli A; Pepi M; Guazzi M
    Cardiologia; 1989 Feb; 34(2):117-25. PubMed ID: 2660989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.